Ancora.ai is an AI-powered platform that supports clinical trials with powerful and patient-friendly technology.
We have three customers: 2 Pharma and 1 CRO. We have a CRO, a Pharma, and several hospitals in our pipeline. We have several partnerships also in place (hospital tech company, e-consent company).
We are the technical backbone for the future of remote clinical trials. Trial sites, CROs and Pharma running trials can use Ancora.ai to provide one seamless experience to patients throughout their participation. Value for CROs/Pharma is patient engagement and for hospitals Ancora.ai helps save time and ensure that trials become part of everyday practice for the first time.
Problem or Opportunity
Patients and physicians struggle with participating in clinical research and with the pandemic stoking fire of digitization in healthcare, clinical trials MUST offer more remote and decentralized services to continue. Ancora.ai is the platform that connects patients and clinicians to trials.
Solution (product or service)
www.ancora.ai or https://www.youtube.com/watch?v=lcDaY7LxKaM&t=10s for product demo.
Companies in similar space include Antidote, Clara Health, Medable.
Advantages or differentiators
Our AI algorithms are proprietary and have taken 3 years to develop. Off-the-shelf ontologies are not useful in the complex world of clinical trials and when providing a patient-friendly experience. We use NLP as the translator to connect patients to clinical research.